当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析 - 现金流量表

天坛生物

(600161)

  

流通市值:253.30亿  总市值:253.30亿
流通股本:19.77亿   总股本:19.77亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,696,273,824.062,412,081,763.9991,221,205.84,734,373,938.47
  收到其他与经营活动有关的现金71,191,642.5246,767,758.636,105,899.8981,028,757.3
  经营活动现金流入小计3,767,465,466.582,458,849,522.51,027,327,105.694,815,402,695.77
  购买商品、接受劳务支付的现金1,777,859,496.611,130,899,395.52543,382,939.132,267,585,618.38
  支付给职工以及为职工支付的现金705,308,569.97472,580,353.32281,149,427.581,212,164,096.4
  支付的各项税费692,575,901.03469,611,704.68174,446,993.57767,125,365.15
  支付其他与经营活动有关的现金181,557,382.9596,401,553.843,855,941.44229,780,957.21
  经营活动现金流出小计3,357,301,350.562,169,493,007.321,042,835,301.724,476,656,037.14
  经营活动产生的现金流量净额410,164,116.02289,356,515.18-15,508,196.03338,746,658.63
二、投资活动产生的现金流量:
  收回投资收到的现金14,150,365.6514,150,365.653,772,865.94-
  取得投资收益收到的现金28,642,489.8326,542,489.8326,542,489.8337,196,956.96
  处置固定资产、无形资产和其他长期资产收回的现金净额55,142.6214,67013,470339,337.03
  处置子公司及其他营业单位收到的现金净额5,134,763.935,134,763.935,134,763.93-
  收到的其他与投资活动有关的现金806,000,000506,000,000506,000,000709,000,000
  投资活动现金流入小计853,982,762.03551,842,289.41541,463,589.7746,536,293.99
  购建固定资产、无形资产和其他长期资产支付的现金464,407,581.43341,623,365.7187,146,547.77605,531,434.31
  支付其他与投资活动有关的现金800,000,000800,000,000800,000,00016,650,000
  投资活动现金流出小计1,264,407,581.431,141,623,365.7987,146,547.77622,181,434.31
  投资活动产生的现金流量净额-410,424,819.4-589,781,076.29-445,682,958.07124,354,859.68
三、筹资活动产生的现金流量:
  取得借款收到的现金317,452,369.4232,602,565.1286,953,347.1286,925,081.38
  筹资活动现金流入小计317,452,369.4232,602,565.1286,953,347.1286,925,081.38
  分配股利、利润或偿付利息支付的现金369,810,174.1125,990,000-706,612,364.61
  其中:子公司支付给少数股东的股利、利润72,874,397.6425,990,000-212,269,503.11
  支付其他与筹资活动有关的现金18,087,571.277,825,191.381,101,139.6722,708,405.57
  筹资活动现金流出小计387,897,745.3833,815,191.381,101,139.67729,320,770.18
  筹资活动产生的现金流量净额-70,445,375.98198,787,373.7485,852,207.43-442,395,688.8
四、汇率变动对现金及现金等价物的影响-39,436.53-29,715.9-14,958.93-28,934.14
五、现金及现金等价物净增加额-70,745,515.89-101,666,903.27-375,353,905.620,676,895.37
  加:期初现金及现金等价物余额1,443,597,800.411,443,597,800.411,443,597,800.411,422,920,905.04
  期末现金及现金等价物余额1,372,852,284.521,341,930,897.141,068,243,894.811,443,597,800.41
补充资料:
  净利润-414,563,879.92-1,489,882,179.7
  资产减值准备-5,684,810.93-19,110,612.28
  固定资产和投资性房地产折旧-177,033,617.54-348,834,129.26
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-177,033,617.54-348,834,129.26
  无形资产摊销-40,183,920.41-76,618,593.93
  长期待摊费用摊销-15,958,703.93-32,280,975.62
  处置固定资产、无形资产和其他长期资产的损失--21,397.95--104,452.59
  固定资产报废损失--7,384.03-2,875,975.18
  财务费用-3,707,352.78-7,364,956.02
  投资损失--9,252,615.18--29,398,010.78
  递延所得税--9,829,950.91--12,871,040.86
  其中:递延所得税资产减少--3,665,929.94--14,651,807.57
    递延所得税负债增加--6,164,020.97-1,780,766.71
  存货的减少--121,726,840.21--172,036,268.91
  经营性应收项目的减少--387,229,377.76--1,375,668,968.71
  经营性应付项目的增加-134,208,594.59--113,339,500.64
  现金的期末余额-1,341,930,897.14-1,443,597,800.41
  减:现金的期初余额-1,443,597,800.41-1,422,920,905.04
  现金及现金等价物的净增加额--101,666,903.27-20,676,895.37
公告日期2026-10-302026-08-292026-04-302026-03-28
审计意见(境内)标准无保留意见
TOP↑